NCT00531583

Completed

Autologous Peripheral Blood Stem Cell Transplantation With I...

King Faisal Specialist Hospital & Research Center Source

ClinicalTrials.gov

Compare

Other study identifiers

Sponsor study identifier

RAC#2001-004

Study Type

interventional

Actual enrollment (reported)

350

Locations

1 country

Sites

1

Timeline

Study Start

March 2001

Date type not reported

This date has not been verified as actual or estimated.

Primary Completion

June 2015

Actual (reported)

Study Completion

June 2015

Actual (reported)

Brief Summary

Autologous peripheral Bld Stem Cell Transplantation with In Vivo Purging as an alternate stem cell transplantation program for pts w/AML in 1st \& 2nd complete remission w/no HLA matched related donor

Registry Overview

Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.

Recruitment status: completed
Actual enrollment (reported): 350 participants
Study completion date: June 2015
Actual (reported)
Listed locations: 1 countries · 1 sites

Trial Relationships

Click on a node to explore related trials.

Some registry-reported names shown below are not yet linked in this graph.

Study Timeline

Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.

Study Start
March 2001
Date type not reported
This date has not been verified as actual or estimated.
First Submitted
September 17, 2007
Actual (reported)
First Posted
September 19, 2007
Actual (reported)
Primary Completion
June 2015
Actual (reported)
Study Completion
June 2015
Actual (reported)

Last Updated: January 5, 2016
Status Verified: January 2016
Last Update Submitted: January 4, 2016

Conditions

Leukemia, Monocytic, Acute

Keywords

AML in 1st & 2nd complete remission w/no HLA matched related donor

Outcome Measures

Primary Outcomes (1)

Efficacy
2009-2015

Interventions

Autologous peripheral Bld Stem Cell Transplantation with In Vivo Purging as an alternate stem cell transplantationDrug

Autologous PBSCT

Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.

Eligibility Criteria

Age18 Years - 85 Years

Sexall

Healthy VolunteersNo

Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

Patients with AML in 1st \& 2nd complete remission w/no HLA matched related donor

Contact the study team to confirm eligibility.

Sponsors & Collaborators

King Faisal Specialist Hospital & Research Center
Otherlead

Study Sites (1)

KFSH&RC

Riyadh, 1211, Saudi Arabia

MeSH Terms

Conditions

Leukemia, Monocytic, Acute

Condition Hierarchy (Ancestors)

Leukemia, Myeloid, AcuteLeukemia, MyeloidLeukemiaNeoplasms by Histologic TypeNeoplasmsHematologic DiseasesHemic and Lymphatic Diseases

Study Officials

Fahad AlMohareb
KFSH&RC
PRINCIPAL INVESTIGATOR

Enrollment

350 participants (actual enrollment reported by the registry).

Study Design

Study Type: interventional
Phase: not applicable
Allocation: NA
Masking: NONE
Purpose: TREATMENT
Intervention Model: SINGLE GROUP
Sponsor Type: OTHER
Responsible Party: SPONSOR

Study Record Dates

First Submitted

September 17, 2007

First Posted

September 19, 2007

Study Start

March 2001

Date type not reported

This date has not been verified as actual or estimated.

Recruiting

Primary Completion

June 2015

Actual (reported)

Study Completion

June 2015

Actual (reported)

Last Updated

January 5, 2016

Record last verified: 2016-01

Source record

Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.

Source: ClinicalTrials.gov.

JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.

Registry identifier: NCT00531583
Data provider: ClinicalTrials.gov
Source updated: 2016-01-05
Normalization version: ctgov-legacy-1

Open registry record

Source retrieved: 2026-10-25 22:27:39 UTC

Locations

SA(1)

Brief Summary

Registry Overview

Trial Relationships

Related Scientific Literature

Study Timeline

Study Start

First Submitted

First Posted

Primary Completion

Study Completion

Conditions

Keywords

Outcome Measures

Primary Outcomes (1)

Interventions

Eligibility Criteria

You may qualify if:

Sponsors & Collaborators

Study Sites (1)

MeSH Terms

Conditions

Condition Hierarchy (Ancestors)

Study Officials

Enrollment

Study Design

Study Record Dates

Source record

Locations